pharma
Sanders calls on Trump to support drug pricing bill
January 11, 2019Medical Communications Bernie Sanders, Trump, access, pharma, pricing
Senator Bernie Sanders has called on President Donald Trump to support new legislation aimed at cutting prices on prescription drugs. …
AstraZeneca to shut down twin Colorado manufacturing sites, impacting over 200 jobs
January 10, 2019Manufacturing and Production AstraZeneca, US, job cuts, pharma
UK-based drug firm AstraZeneca has revealed it is set to shed more than 200 positions from its operations at two …
NICE rejects Novartis’ Aimovig migraine injection for NHS use
January 10, 2019Sales and Marketing Aimovig, NICE, Novartis, migraine, pharma
It’s disappointing news for Novartis as NICE revealed that it had decided not to recommend Aimovig (erenumab) for routine NHS …
Amgen and UCB’s Evenity approved in Japan for osteoporosis
January 9, 2019Research and Development, Sales and Marketing Amgen, Japan, UCB Pharma, osteoporosis, pharma
Amgen has revealed that its bone-forming monoclonal antibody Evenity (romosozumab), developed in partnership with UCB Pharma, has been awarded approval …
Death row inmate whose execution was postponed found dead in cell
January 9, 2019Research and Development Alvogen, Scott Dozier, execution, pharma, prison
Scott Dozier, the death row inmate whose execution was stalled by court cases launched by pharmaceutical companies, has been found …
Pfizer to shutter two manufacturing plants in India, 1,700 jobs at risk
January 9, 2019Manufacturing and Production, Research and Development India, Pfizer, pharma
Pfizer has announced it is to shut down two of its manufacturing facilities in India – a move which could …
bluebird bio reveals new UK General Manager
January 9, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, appointment, pharma
bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions, has named Nicola Redfern …
Two biomarkers can aid in atrial fibrillation screening, researchers find
January 8, 2019Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma
A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …
Takeda completes Shire acquisition
January 8, 2019Manufacturing and Production M&A, MA, Shire, Takeda, acquisition, deal, pharma
Japanese firm Takeda Pharmaceuticals has successfully completed its acquisition of Shire Plc. The long anticipated deal has propelled the firm …
Roche’s Genentech inks potential $2bn personalised cancer drug development deal
January 7, 2019Sales and Marketing Adaptive Biotechnologies, Cancer, Genentech, Roche, oncology, pharma
Roche’s Genentech is set to enter into a deal with Adaptive Biotechnologies to bolster its pursuits in the treatment of …
How tech is powering precision treatment
January 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Precision Medicine, pharma, tech
As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …
Promising interim Phase 3 data spurs epidermolysis bullosa trial expansion for Amryt
January 7, 2019Research and Development, Sales and Marketing Amryt, epidermolysis bullosa, pharma, rare disease
Rare disease firm Amryt has announced interim efficacy data for its epidermolysis bullosa (EB) therapy AP101, showing that things are …
Sanofi will pay Regeneron $582m in deal restructuring
January 7, 2019Sales and Marketing Deals, Regeneron, Sanofi, biotech, pharma
French pharmaceutical giant Sanofi will pay US biotech Regeneron $582 million, as part of a restructuring of an earlier deal …
Aevi Genomic Medicine’s share price crashes 75% following ADHD trial failure
January 4, 2019Medical Communications, Research and Development ADHD, AEVI-001, Aevi Genomic Medicine, clinical trial failure, pharma
Aevi Genomic Medicine, a US drugmaker based outside of Philadelphia, has seen its share value plummet by 75% following the …
NICE recommends AstraZeneca’s Fasenra as third treatment option for severe asthma
January 4, 2019Medical Communications, Sales and Marketing AstraZeneca, Fasenra, NHS, NICE, UK, asthma, pharma
It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
